US Bancorp’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2K | Sell |
1,699
-28
| -2% | -$647 | ﹤0.01% | 2890 |
|
|
2025
Q1 | $46.6K | Buy |
1,727
+1,658
| +2,403% | +$44.8K | ﹤0.01% | 2778 |
|
|
2024
Q4 | $3.69K | Sell |
69
-19
| -22% | -$1.02K | ﹤0.01% | 3722 |
|
|
2024
Q3 | $4K | Sell |
88
-121
| -58% | -$5.5K | ﹤0.01% | 3629 |
|
|
2024
Q2 | $8.76K | Buy |
209
+195
| +1,393% | +$8.17K | ﹤0.01% | 3348 |
|
|
2024
Q1 | $527 | Sell |
14
-76
| -84% | -$2.86K | ﹤0.01% | 3844 |
|
|
2023
Q4 | $966 | Hold |
90
| – | – | ﹤0.01% | 3790 |
|
|
2023
Q3 | $907 | Hold |
90
| – | – | ﹤0.01% | 3761 |
|
|
2023
Q2 | $1.07K | Hold |
90
| – | – | ﹤0.01% | 3764 |
|
|
2023
Q1 | $1.09K | Buy |
+90
| New | +$1.09K | ﹤0.01% | 3834 |
|
|
2021
Q3 | – | Sell |
-7
| Closed | – | – | 4082 |
|
|
2021
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4003 |
|